Relative IC50 for two “known” and two “novel” compounds in both BL2-NFκB-Luc and Ramos-NFκB-Luc cell lines.

Alexandra Zhernakova (102388); Cathy Hartland (413167); Di Wu (23906); Dorothée Diogo (132296); Eli Stahl (33862); Elizabeth J. Rossin (233194); Fina Kurreeman (413165); Gang Li (34549); Grant Duclos (413166); Jane Worthington (23502); Jim Spoonamore (413163); John Bowes (413170); Jun Liu (42548); Katherine A. Siminovitch (210196); Kejie Li (413169); Leonid Padyukov (39206); Lude Franke (102406); Namrata Gupta (229166); Nicola Tolliday (413171); Paul A. Clemons (226714); Peter K. Gregersen (94588); Philip L. De Jager (202972); Robert M. Plenge (120861); Soumya Raychaudhuri (229153); Steve Eyre (120809); Vlado Dancik (413164); Xuezhong Zhou (413168)

Relative IC50 for two “known” and two “novel” compounds in both BL2-NFκB-Luc and Ramos-NFκB-Luc cell lines.

Abstract

Relative IC50 is the concentration required to bring the dose-response curve to the halfway point between the top and bottom plateaus of the curve.</p

Similar works

Full text

Available Versions

The Francis Crick Institute

oai:figshare.com:article/70412...

Last time updated on 12/02/2018

Relative IC<sub>50</sub> for two “known” and two “novel” compounds in both BL2-NFκB-Luc and Ramos-NFκB-Luc cell lines.

Abstract

Similar works

Full text

Available Versions

The Francis Crick Institute